C
AbbVie Inc. ABBV
$210.60 $1.100.53% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 3.76B 4.20B 4.28B 5.12B 5.34B
Total Depreciation and Amortization 8.27B 8.35B 8.39B 8.36B 8.52B
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 10.04B 9.46B 8.92B 4.97B 4.85B
Change in Net Operating Assets -2.79B -5.61B -2.78B -1.94B -65.00M
Cash from Operations 19.28B 16.40B 18.81B 16.51B 18.64B
Capital Expenditure -1.04B -1.02B -974.00M -888.00M -858.00M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -11.76B -11.67B -20.52B -19.28B -10.94B
Divestitures -- -- -- -- --
Other Investing Activities 761.00M 715.00M 671.00M 420.00M -59.00M
Cash from Investing -12.05B -11.97B -20.82B -19.75B -11.86B
Total Debt Issued 11.55B 7.59B 21.97B 19.97B 19.97B
Total Debt Repaid -12.95B -12.54B -14.62B -10.65B -10.25B
Issuance of Common Stock 138.00M 143.00M 214.00M 235.00M 204.00M
Repurchase of Common Stock -1.35B -1.35B -1.71B -1.35B -1.34B
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -11.34B -11.18B -11.03B -10.90B -10.78B
Other Financing Activities 42.00M 44.00M -42.00M -100.00M -196.00M
Cash from Financing -13.90B -17.29B -5.21B -2.80B -2.39B
Foreign Exchange rate Adjustments 1.00M -38.00M -65.00M 4.00M -20.00M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -6.66B -12.89B -7.29B -6.03B 4.37B